Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma.

Hsu, Chia-Lang; Ou, Da-Liang; Bai, Li-Yuan; Chen, Chia-Wei; Lin, Li; Huang, Shiu-Feng; Cheng, Ann-Lii; Jeng, Yung-Ming; Hsu, Chiun

Hsu, Chia-Lang; Ou, Da-Liang; Bai, Li-Yuan; Chen, Chia-Wei; Lin, Li; Huang, Shiu-Feng; Cheng, Ann-Lii; Jeng, Yung-Ming; Hsu, Chiun.

Afiliación

Hsu CL; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Ou DL; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.
Bai LY; Graduate Institute of Medical Genomics and Proteomics, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen CW; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.
Lin L; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital and China Medical University, Taichung, Taiwan.
Huang SF; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.
Cheng AL; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.
Jeng YM; Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
Hsu C; National Taiwan University Cancer Center, Taipei, Taiwan.

Liver Cancer ; 10(4): 346-359, 2021 Jul.

Article en En | MEDLINE | ID: mdl-34414122

Palabras clave

Anti-PD-1; Anti-PD-L1; Immune checkpoint inhibitor; T-cell exhaustion; Tumor microenvironment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Liver Cancer Año: 2021 Tipo del documento: Article País de afiliación: Taiwán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google